Related Experiment Video

Updated: Jun 22, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma

Jamal Shamsara1, Samaneh Sharif, Sima Afsharnezhad

  • 1Biotechnology Research Center, Mashhad, Iran.

Cancer Investigation
|June 23, 2009
PubMed

Insights

Epigenetic silencing of O(6)-methylguanine-DNA methyltransferase (MGMT) via promoter hypermethylation occurs in 48% of glioblastoma. This MGMT inactivation is linked to p53 mutations, impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • O(6)-methylguanine-DNA methyltransferase (MGMT) is a crucial DNA repair enzyme.
  • MGMT promoter hypermethylation leads to its transcriptional silencing in various cancers.
  • Glioblastoma, a highly aggressive brain tumor, often exhibits MGMT alterations.

Purpose of the Study:

  • To investigate the frequency of MGMT promoter methylation in glioblastoma.
  • To explore the association between MGMT methylation and p53 mutation status in glioblastoma.
  • To understand the role of epigenetic MGMT inactivation in glioblastoma pathogenesis.

Main Methods:

  • Methylation-specific PCR (MSP) was employed to assess MGMT promoter methylation in 50 glioblastoma samples.
  • Immunohistochemical analysis was used to detect mutant p53 expression in the same tumor cohort.

Main Results:

  • MGMT promoter hypermethylation was identified in 24 out of 50 (48%) glioblastoma samples.
  • A statistically significant association was observed between MGMT methylation and p53 mutation status (p < .05).

Conclusions:

  • Epigenetic inactivation of MGMT through promoter hypermethylation is a frequent event in glioblastoma.
  • MGMT methylation status is significantly correlated with p53 mutation, suggesting a role in glioblastoma development and progression.
  • These findings highlight the importance of MGMT epigenetic status in glioblastoma patient outcomes.

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.